Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Inner-City Anti-IgE Therapy for Asthma

ClinicalTrials.gov ID: NCT00377572

Public ClinicalTrials.gov record NCT00377572. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 1, 2026, 12:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Inner-City Anti-IgE Therapy for Asthma (ICAC-08)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to find out if adding omalizumab to standard asthma treatment results in a safer, more effective, and longer lasting asthma treatment strategy than standard treatment alone, in inner-city children with mild to severe asthma.

Study identification

NCT ID
NCT00377572
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Enrollment
419 participants

Conditions and interventions

Conditions

Interventions

Biological

Eligibility (public fields only)

Age range
6 Years to 20 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2006
Primary completion
Nov 30, 2009
Completion
Nov 30, 2009
Last update posted
Mar 20, 2017

2006 – 2009

United States locations

U.S. sites
8
U.S. states
8
U.S. cities
8
Facility City State ZIP Site status
University of Arizona Health Sciences Center Tucson Arizona 245018
National Jewish Medical and Research Center Denver Colorado 80206
Children's National Medical Center Washington D.C. District of Columbia 20010
Children's Memorial Hospital Chicago Illinois 60614
Boston University School of Medicine Boston Massachusetts 02118
Columbia University Medical Center New York New York 10029
Rainbow Babies and Children's Hospital Cleveland Ohio 44106
University of Texas Southwestern Medical Center Dallas Texas 75390

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00377572, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 20, 2017 · Synced Sep 1, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00377572 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →